Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmaSurgics
Gothenburg, Swedenpharmasurgics.se ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Completed Phase I showing safety/tolerability of PXL01. Entered Phase II proof-of-concept study for flexor tendon repair surgery, aiming to become first pharmaceutical anti-adhesion product.
- Therapeutic areas
- OtherDermatology
- Modalities
- synthetic peptidesphysical barrier vehicle combined with pharmacological agent
- Industry
- Biotech
02
Partnerships
Karolinska Development AB Portfolio company relationshipSahlgrenska University Hospital Research collaboration
Beyond the preview
Go deeper on PharmaSurgics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PharmaSurgics.